↓ Skip to main content

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Overview of attention for article published in Annals of Surgical Oncology, July 2018
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
46 Mendeley
Title
Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Published in
Annals of Surgical Oncology, July 2018
DOI 10.1245/s10434-018-6637-9
Pubmed ID
Authors

Toan T. Nguyen, Tanya L. Hoskin, Courtney N. Day, Amy C. Degnim, James W. Jakub, Tina J. Hieken, Judy C. Boughey

Abstract

Neoadjuvant chemotherapy (NAC) may downstage axillary disease in node-positive breast cancer. Several clinical trials have shown that sentinel lymph node (SLN) surgery after NAC is feasible for these patients. We sought to evaluate the use of SLN surgery and ALND in cN1 patients undergoing NAC. We identified all patients with biopsy-proven cN1 breast cancer treated with NAC at our institution between January 2009 and December 2017. Approximated biologic subtype was determined by estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status. Cochran-Armitage trend and Chi square tests were used for statistical analysis. Of 430 cN1 patients treated with NAC, 93 (22%) underwent SLN surgery only, 100 (23%) underwent SLN and ALND, and 237 (55%) underwent ALND only. The use of SLN surgery (± ALND) increased from 28% in 2009 to 86% in 2017 (p < 0.001), while the performance of ALND decreased from 100% in 2009 to 38% in 2017 (p < 0.001). Among SLN+ patients who underwent ALND, disease was limited to the SLNs in 25/73 (34%) patients. The nodal pathologic complete response rate was 46% and varied by tumor subtype (p < 0.001). Among patients undergoing SLN surgery, ALND was avoided in 48% of patients overall and varied by biologic subtype: 55% ER-/HER2+, 61% ER+/HER2+, 62% ER-/HER2-, and 31% ER+/HER2- (p = 0.001). With short-term follow-up, no nodal recurrences have occurred in patients without ALND. We observed a significant shift in axillary surgery for cN1 breast cancer patients treated with NAC, with increasing use of SLN surgery to assess nodal treatment response, and decreasing use of ALND.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Other 9 20%
Student > Ph. D. Student 5 11%
Student > Bachelor 5 11%
Researcher 4 9%
Professor > Associate Professor 3 7%
Other 6 13%
Unknown 14 30%
Readers by discipline Count As %
Medicine and Dentistry 25 54%
Nursing and Health Professions 1 2%
Sports and Recreations 1 2%
Agricultural and Biological Sciences 1 2%
Social Sciences 1 2%
Other 1 2%
Unknown 16 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2018.
All research outputs
#15,539,088
of 23,094,276 outputs
Outputs from Annals of Surgical Oncology
#4,456
of 6,549 outputs
Outputs of similar age
#209,136
of 327,552 outputs
Outputs of similar age from Annals of Surgical Oncology
#110
of 126 outputs
Altmetric has tracked 23,094,276 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,549 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,552 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 126 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.